Ezetimibe Induces Vasodilation in Rat Mesenteric Resistance Arteries through Inhibition of Extracellular Ca(2+) Influx

Ezetimibe is a lipid-lowering agent that selectively inhibits cholesterol absorption by binding to the Niemann–Pick C1-like 1 (NPC1L1) protein. Although it is well known that administration of ezetimibe in hypercholesterolemia patients reduces the risk of cardiovascular events through attenuation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Eun Yi, Haam, Chae Eun, Choi, Sooyeon, Byeon, Seonhee, Choi, Soo-Kyoung, Lee, Young-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531054/
https://www.ncbi.nlm.nih.gov/pubmed/37762296
http://dx.doi.org/10.3390/ijms241813992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531054/
https://www.ncbi.nlm.nih.gov/pubmed/37762296
http://dx.doi.org/10.3390/ijms241813992

Ejemplares similares